Alunbrig (ARIAD Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Alunbrig drug offered from ARIAD Pharmaceuticals Inc.. This Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ARIAD Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Brigatinib |
SUBSTANCE NAME: | BRIGATINIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-04-28 |
END MARKETING DATE: | 0000-00-00 |
Alunbrig HUMAN PRESCRIPTION DRUG Details:
Item Description | Alunbrig from ARIAD Pharmaceuticals Inc. |
LABELER NAME: | ARIAD Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/1) |
START MARKETING DATE: | 2017-04-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76189-113_d485ee73-d30f-4a14-ae43-474317f1643e |
PRODUCT NDC: | 76189-113 |
APPLICATION NUMBER: | NDA208772 |
Other BRIGATINIB Pharmaceutical Manufacturers / Labelers: